In the present study, we found that Ngn2 expression decreased in the hippocampus and in primary cultured hippocampal neurons in the acute stage after ischemic injury, assessed both in vivo and in vitro in an experimental stroke model, which indicated that Ngn2 represents a potential valuable target molecule for stroke therapy. This evidence concerns the gene NEUROG2 and Stroke.